Meropenem en es it fr

Meropenem Brand names, Meropenem Analogs

Meropenem Brand Names Mixture

  • No information avaliable

Meropenem Chemical_Formula

C17H25N3O5S

Meropenem RX_link

http://www.rxlist.com/cgi/generic2/meropen.htm

Meropenem fda sheet

Meropenem FDA

Meropenem msds (material safety sheet)

Meropenem Synthesis Reference

No information avaliable

Meropenem Molecular Weight

383.464 g/mol

Meropenem Melting Point

No information avaliable

Meropenem H2O Solubility

Sparingly

Meropenem State

Solid

Meropenem LogP

0.33

Meropenem Dosage Forms

Powder for solution (for injection)

Meropenem Indication

For use as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms: complicated skin and skin structure infections due to Staphylococcus aureus (b-lactamase and non-b-lactamase producing, methicillin-susceptible isolates only), Streptococcus pyogenes, Streptococcus agalactiae, viridans group streptococci, Enterococcus faecalis (excluding vancomycin-resistant isolates), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis and Peptostreptococcus species; complicated appendicitis and peritonitis caused by viridans group streptococci, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacteroides fragilis, B. thetaiotaomicron, and Peptostreptococcus species. Also for use in the treatment of bacterial meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (b-lactamase and non-b-lactamase-producing isolates), and Neisseria meningitidis.

Meropenem Pharmacology

Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death.

Meropenem Absorption

No information avaliable

Meropenem side effects and Toxicity

In mice and rats, large intravenous doses of meropenem (2200-4000 mg/kg) have been associated with ataxia, dyspnea, convulsions, and mortalities.

Meropenem Patient Information

Meropenem Organisms Affected

Enteric bacteria and other eubacteria